Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

Abstract

CYTOGENETIC abnormalities of chromosome 9p21 are characteristic of malignant melanomas1,2, gliomas3, lung cancers4 and leukaemias5. From a panel of 46 human malignant cell lines, we localized by positional cloning the most frequently deleted region on 9p21. Sequence analysis of the isolated fragment reveals two open reading frames identical to the recently described complementary DNA for the inhibitor of cyclin-dependent kinase 4 (CDK4) 6. Polymerase chain reaction and Southern blot analysis confirmed the frequent deletion or rearrangement of the CDK4-inhibitor gene in melanomas, gliomas, lung cancers and leukaemias, and the absence of detectable gene transcripts. One carcinoma had a deletion entirely within the CDK4-inhibitor gene. The CDK4-inhibitor gene from a patient with dysplastic nevus syndrome had a germ-line nonsense mutation. The CDK4 inhibitor is thought to be a physiological suppressor of proliferation. Cells unable to produce the inhibitor may be prone to neoplastic transformation.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Fountain, J. E. et al. Proc. natn. Acad. Sci. U.S.A. 89, 10557–10561 (1992).

    ADS  CAS  Article  Google Scholar 

  2. 2

    Petty, E. M. et al. Am. J. hum. Genet. 53, 96–104 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  3. 3

    Olopade, O. I. et al. Cancer Res. 52, 2523–2529 (1992).

    CAS  PubMed  Google Scholar 

  4. 4

    Olopade, O. I. et al. Cancer Res. 53, 2410–2415 (1993).

    CAS  PubMed  Google Scholar 

  5. 5

    Olopade, O. I. et al. Genomics 14, 437–443 (1992).

    CAS  Article  Google Scholar 

  6. 6

    Serrano, M., Hannon, G. J. & Beach, D. Nature 366, 704–707 (1993).

    ADS  CAS  Article  Google Scholar 

  7. 7

    Nobori, T. et al. Cancer Res. 51, 3193–3197 (1991).

    CAS  PubMed  Google Scholar 

  8. 8

    Nobori, T. et al. Cancer Res. 53, 1098–10101 (1993).

    CAS  PubMed  Google Scholar 

  9. 9

    Pierce, J. C. & Sternberg, N. L. Meth. Enzym. 216, 549–574 (1992).

    CAS  Article  Google Scholar 

  10. 10

    Marx, J. Science 263, 319–321 (1994).

    ADS  CAS  Article  Google Scholar 

  11. 11

    Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. & Elledge, S. J. Cell 75, 805–816 (1993).

    CAS  Article  Google Scholar 

  12. 12

    Xiong, Y. et al. Nature 366, 701–704 (1993).

    ADS  CAS  Article  Google Scholar 

  13. 13

    Cannon-Albright, L. A. et al. Science 258, 1148–1152 (1992)

    ADS  CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Nobori, T., Miura, K., Wu, D. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753–756 (1994). https://doi.org/10.1038/368753a0

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing